Laura Williams

Laura Williams

Corporate Officer/Principal at ARDELYX, INC.

Net worth: 2 M $ as of 30/07/2026

63 year
Health Technology
Consumer Services

Profile

Laura A. Williams is Chief Patient Officer at Ardelyx, Inc. since 2025.
Formerly, Dr. Williams was Independent Director at Imara, Inc. from 2021 to 2023, Senior Vice President-Clinical Development at AMAG Pharmaceuticals, Inc. from 2017 to 2020, and Vice President-Clinical Development at Myovant Sciences, Inc. from 2016 to 2017.
Education includes graduate studies at the University of Washington, undergraduate studies at Mississippi State University, and a doctorate from the University of Iowa.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/06/2026 378,195 ( 0.15% ) 2 M $ 30/07/2026

Laura Williams active positions

CompaniesPositionStart
ARDELYX, INC. Corporate Officer/Principal 31/12/2024

Former positions of Laura Williams

CompaniesPositionEnd
IMARA Director/Board Member 31/01/2023
AMAG PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 31/12/2019
Chief Tech/Sci/R&D Officer 31/07/2017
See the detail of Laura Williams's experience

Training of Laura Williams

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Laura Williams